Elena Guillén
Leiden University Medical Center(NL)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, CAR-T cell therapy research, Biosimilars and Bioanalytical Methods, Peptidase Inhibition and Analysis
Most-Cited Works
- → Enrichment of Rare Variants in Loeys–Dietz Syndrome Genes in Spontaneous Coronary Artery Dissection but Not in Severe Fibromuscular Dysplasia(2020)44 cited
- → Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy(2020)28 cited
- → Oral hydration compared to intravenous hydration in the prevention of post-contrast acute kidney injury in patients with chronic kidney disease stage IIIb: A phase III non-inferiority study (NICIR study)(2021)26 cited
- → A Data Driven Approach to Support Tailored Clinical Programs for Biosimilar Monoclonal Antibodies(2022)26 cited
- → Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?(2023)21 cited
- → The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (ARI‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell non‐Hodgkin lymphoma(2023)19 cited
- → Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma(2024)17 cited
- → Academic challenges on advanced therapy medicinal products’ development: a regulatory perspective(2024)16 cited
- → The real-world use and effectiveness of avacopan in routine practice for the treatment of ANCA vasculitis. First experiences in Spain(2024)15 cited
- → Evaluation of the influence of the surface membrane and blood flow in medium «cut-off» (MCO) dialyzers(2019)14 cited